Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review
CA: A Cancer Journal for Clinicians · 2026-03 · 76 (2)
DOI: 10.3322/caac.70075 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CA: A Cancer Journal for Clinicians, online erschienen am 03.03.2026. Verfasst von Brittany L Greene und 1 weiteren Autor:innen. Beteiligte Einrichtung: Seattle Children's Research Institute, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Genetic Testing, Neoplasms, Medical Oncology, Pediatrics. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Seattle Children's Research Institute, Clinical Research Scholars Program.
Abstract (Originalsprache)
Genomics—and genomic testing in particular—has transformed oncology, facilitating both targeted therapies and personalized care. In pediatric oncology, unique clinical and ethical considerations arise. Compared with adults, children and adolescents are affected by more limited evidence regarding test performance, variant interpretation, and the clinical utility of genomically informed interventions. Nevertheless, genomic findings may have implications beyond the patient, affecting their parents, siblings, and other relatives and raising questions around consent, assent, privacy, and psychosocial impact. This narrative review examines how ethical dimensions of genetic and genomic testing evolve across the pediatric cancer continuum, from diagnosis and treatment through survivorship and transition to adult care. Attention is given to communication strategies, interdisciplinary support, and equity concerns that influence the responsible integration of genomic medicine. The authors also identify priority areas for future inquiry, including incorporation of children's perspectives, longitudinal approaches to recontact and reconsent, and better understanding of how genomic information affects treatment decision‐making. Pediatric genetic and genomic testing in oncology holds great promise, but its benefits can only be realized through thoughtfully developed and standardized communication practices, careful ethical deliberation, and equitable implementation. By proactively addressing these issues, pediatric oncologists can harness genomic advances in ways that respect and support children and their families.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Seattle Children's Research Institute, Seattle, Washington, USA.
- Department of Pediatrics, University of Washington, Seattle, Washington, USA.
- Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA.
- Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.
- Center for Bioethics, Harvard Medical School, Boston, Massachusetts, USA.
ORCID-Profile: Brittany L Greene, Jonathan M Marron
Förderung
- Seattle Children's Research Institute, Clinical Research Scholars Program
Zitieren
APA
Greene, B. L., & Marron, J. M. (2026). Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review. CA: A Cancer Journal for Clinicians, 76(2). https://doi.org/10.3322/caac.70075
Vancouver
Greene BL, Marron JM. Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review. CA: A Cancer Journal for Clinicians. 2026;76(2). doi:10.3322/caac.70075
BibTeX
@article{Greene2026,
author = {Greene, Brittany L and Marron, Jonathan M},
title = {Ethical considerations of genetic and genomic testing in pediatric oncology: A narrative review},
journal = {CA: A Cancer Journal for Clinicians},
year = {2026},
volume = {76},
number = {2},
doi = {10.3322/caac.70075}
}
EUVIMED